Undisclosed CDH17-targeting CD3xCD28 trispecific TCE
/ Biocytogen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 02, 2026
A Novel CDH17-Targeting CD3xCD28 Trispecific T-Cell Engager Demonstrates Potent Anti-Tumor Activity against Colorectal Cancer in Preclinical Models
(SITC 2026)
- No abstract available
Preclinical • Trispecific • Colorectal Cancer • Oncology • Solid Tumor • CDH17
1 to 1
Of
1
Go to page
1